These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30700151)

  • 1. Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis.
    Khan SU; Ul Abideen Asad Z; Khan MU; Talluri S; Ali F; Shahzeb Khan M; Lone AN; Mookadam F; Krasuski RA; Kaluski E
    Eur J Prev Cardiol; 2020 Dec; 27(19):2034-2041. PubMed ID: 30700151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
    Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
    Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
    Kunutsor SK; Seidu S; Khunti K
    Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis.
    Caldeira D; Alves M; David C; Costa J; Ferreira JJ; Pinto FJ
    Prim Care Diabetes; 2020 Jun; 14(3):213-221. PubMed ID: 31791903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.
    Butalia S; Leung AA; Ghali WA; Rabi DM
    Cardiovasc Diabetol; 2011 Apr; 10():25. PubMed ID: 21453547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.
    Zheng SL; Roddick AJ
    JAMA; 2019 Jan; 321(3):277-287. PubMed ID: 30667501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.
    Gelbenegger G; Postula M; Pecen L; Halvorsen S; Lesiak M; Schoergenhofer C; Jilma B; Hengstenberg C; Siller-Matula JM
    BMC Med; 2019 Nov; 17(1):198. PubMed ID: 31679516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis.
    Simpson SH; Gamble JM; Mereu L; Chambers T
    J Gen Intern Med; 2011 Nov; 26(11):1336-44. PubMed ID: 21647746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis.
    Wang M; Yu H; Li Z; Gong D; Liu X
    Am J Cardiovasc Drugs; 2022 Nov; 22(6):657-675. PubMed ID: 35570250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
    Sacco M; Pellegrini F; Roncaglioni MC; Avanzini F; Tognoni G; Nicolucci A;
    Diabetes Care; 2003 Dec; 26(12):3264-72. PubMed ID: 14633812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
    Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
    JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
    Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
    High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Meta-Analysis of Aspirin for the Primary Prevention of Cardiovascular Diseases in the Context of Contemporary Preventive Strategies.
    Shah R; Khan B; Latham SB; Khan SA; Rao SV
    Am J Med; 2019 Nov; 132(11):1295-1304.e3. PubMed ID: 31153866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and Risks Associated With Aspirin Use in Patients With Diabetes for the Primary Prevention of Cardiovascular Events and Mortality: A Meta-Analysis.
    Ma H; Gu Q; Niu H; Li X; Wang R
    Front Endocrinol (Lausanne); 2021; 12():741374. PubMed ID: 34539583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials.
    Seidu S; Kunutsor SK; Sesso HD; Gaziano JM; Buring JE; Roncaglioni MC; Khunti K
    Cardiovasc Diabetol; 2019 Jun; 18(1):70. PubMed ID: 31159806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.
    Calvin AD; Aggarwal NR; Murad MH; Shi Q; Elamin MB; Geske JB; Fernandez-Balsells MM; Albuquerque FN; Lampropulos JF; Erwin PJ; Smith SA; Montori VM
    Diabetes Care; 2009 Dec; 32(12):2300-6. PubMed ID: 19741185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
    ; Bowman L; Mafham M; Wallendszus K; Stevens W; Buck G; Barton J; Murphy K; Aung T; Haynes R; Cox J; Murawska A; Young A; Lay M; Chen F; Sammons E; Waters E; Adler A; Bodansky J; Farmer A; McPherson R; Neil A; Simpson D; Peto R; Baigent C; Collins R; Parish S; Armitage J
    N Engl J Med; 2018 Oct; 379(16):1529-1539. PubMed ID: 30146931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of low-dose aspirin on primary prevention of cardiovascular events: a systematic review].
    Tang HQ; Yang LL; Hu SL; Shen G; Sun YH; Huang XH; Li JH; Xu TJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Apr; 38(4):315-20. PubMed ID: 20654075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis.
    Younis N; Williams S; Ammori B; Soran H
    Expert Opin Pharmacother; 2010 Jun; 11(9):1459-66. PubMed ID: 20429671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.